Q2 2019

Filed May 7, 2021 · 10-Q · 677 days after period end · 0001398432-21-000040

Q2 2019 · 10-Q

Revenue

$10.22K

−65.2% vs Q2 2018

Net Income

-$1.67M

N/M vs Q2 2018

EPS Diluted

$0.00

— vs Q2 2018

Gross Profit$6,441−49.7%

Operating Income

Same quarter

Metric	Q2 2019	Q2 2018	Q2 2017	Q2 2016
Revenue	$10.22K	$29.38K	$33.18K	$30.68K
Net Income	-$1.67M	-$1.35M	-$1.12M	-$653.93K
EPS Diluted	$0.00	$0.00	$0.00	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR